Zepbound: The Game-Changing Weight Loss Solution
Learn about the trial results of Zepbound, a new weight loss medication that has shown significant success in helping patients lose weight.
Latest right now for #pharmaceuticals
Trump's Pharma Tariffs: Rethinking US Drug Supply Chains
US imposes 100% tariffs on branded pharmaceuticals, reshaping supply chains and global trade.
Trump Announces 100% Tariff on Patented Pharmaceuticals
President Donald Trump's new tariff on pharmaceuticals may have a significant impact on the industry and healthcare in the United States.
UK and South Korea Strike Trade Deal Deepens Ties in Pharma, Cars, and Finance
UK and South Korea sign an upgraded trade pact boosting pharma, car manufacturing and financial services with clearer market access.
Trump Imposes Tariffs on Copper and Threatens Pharmaceutical Imports
President Donald Trump announces new tariffs on copper and potential consequences for the pharmaceutical industry.
Wegovy Pill Approved by US FDA for Weight Loss and CV Risk Reduction
The FDA approves Wegovy as the first oral GLP-1 therapy for long-term weight management and cardiovascular risk reduction.
Trump's New Tariffs and the Impact on Copper and Pharmaceuticals
President Donald Trump's announcement of new tariffs on copper and potential threats on pharmaceuticals raises concerns for multiple industries and global markets.
GSK Investments in U.S. Healthcare Industry
British pharmaceutical giant GSK announces $30 billion investment to strengthen presence in American market.
Eli Lilly's $5 Billion Investment in New Virginia Facility to Boost Production of Critical Medicines
Eli Lilly announces plans to construct a new facility in Virginia with state-of-the-art technology and a capacity to produce various medicines, showing dedication to enhancing healthcare and advancing medical research.
Trump's New Tariffs on Pharmaceuticals Spark Concerns and Confusion
President Trump's recent announcement of new tariffs on pharmaceutical products has raised concerns about the impact on patented drugs and confusion surrounding exemptions.
